Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209–249.
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–2150.
   PubMed Web of Science ®Google Scholar
• Ajani JA, Lee J, Sano T, et al. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036.
   PubMed Web of Science ®Google Scholar
• Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. Jama. 2010;303(17):1729–1737.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Ianaro A, de Nucci G. Gaseous mediators in gastrointestinal mucosal defense and injury. Dig Dis Sci. 2017;62(9):2223–2230.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Saha S, Giri K, et al. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 2013;8(11):e79167.
   PubMed Web of Science ®Google Scholar
• Chen S, Yue T, Huang Z, et al. Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells. Cancer Lett. 2019;466:49–60.
   PubMed Web of Science ®Google Scholar
• Yue T, Zuo S, Bu D, et al. Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS. J Cancer. 2020;11(7):1828–1838.
   PubMed Web of Science ®Google Scholar
• Sen S, Kawahara B, Gupta D, et al. Role of cystathionine β-synthase in human breast cancer. Free Radic Biol Med. 2015;86:228–238.
   PubMed Web of Science ®Google Scholar
• Wang M, Yan J, Cao X, et al. Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1α activation. Biochem Pharmacol. 2020;172:113775.
   PubMed Web of Science ®Google Scholar
• Szczesny B, Marcatti M, Zatarain JR, et al. Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics. Sci Rep. 2016;6(1):36125.
   PubMedGoogle Scholar
• Shackelford RE, Abdulsattar J, Wei EX, et al. Increased nicotinamide phosphoribosyltransferase and cystathionine-β-synthase in renal oncocytomas, renal urothelial carcinoma, and renal clear cell carcinoma. Anticancer Res. 2017;37(7):3423–3427.
   PubMed Web of Science ®Google Scholar
• Sogutdelen E, Pacoli K, Juriasingani S, et al. Patterns of expression of H 2 S-Producing Enzyme in human renal cell carcinoma specimens: potential avenue for future therapeutics. In Vivo. 2020;34(5):2775–2781.
   PubMed Web of Science ®Google Scholar
• Turbat-Herrera EA, Kilpatrick MJ, Chen J, et al. Cystathione β-synthase is increased in thyroid malignancies. Anticancer Res. 2018;38(11):6085–6090.
   PubMed Web of Science ®Google Scholar
• Wahafu W, Gai J, Song L, et al. Increased H(2)S and its synthases in urothelial cell carcinoma of the bladder, and enhanced cisplatin-induced apoptosis following H(2)S inhibition in EJ cells. Oncol Lett. 2018;15(6):8484–8490.
   PubMed Web of Science ®Google Scholar
• Li D, Yang Z, Liu Z, et al. Clinical significance of CBS and CCL21 in gallbladder adenocarcinomas and squamous cell/adenosquamous carcinomas. Appl Immunohistochem Mol Morphol. 2020;28(2):103–110.
   PubMedGoogle Scholar
• Kim J, Hong SJ, Park JH, et al. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol Rep. 2009;21(6):1449–1454.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qi Q, Yang J, et al. An anticancer role of hydrogen sulfide in human gastric cancer cells. Oxid Med Cell Longev. 2015;2015:636410.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li Q, Wang J, et al. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. PLoS One. 2012;7(11):e49683.
   PubMed Web of Science ®Google Scholar
• Szabo C, Coletta C, Chao C, et al. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci U S A. 2013;110(30):12474–12479.
   PubMed Web of Science ®Google Scholar
• Youness RA, Gad AZ, Sanber K, et al. Targeting hydrogen sulphide signaling in breast cancer. J Adv Res. 2021;27:177–190.
   PubMed Web of Science ®Google Scholar
• Takano N, Sarfraz Y, Gilkes DM, et al. Decreased expression of cystathionine β-synthase promotes glioma tumorigenesis. Mol Cancer Res. 2014;12(10):1398–1406.
   PubMed Web of Science ®Google Scholar
• Pagliara V, Saide A, Mitidieri E, et al. 5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53. Oncotarget. 2016;7(31):50333–50348.
   PubMedGoogle Scholar
• Ye F, Li X, Sun K, et al. Inhibition of endogenous hydrogen sulfide biosynthesis enhances the anti-cancer effect of 3,3ʹ-diindolylmethane in human gastric cancer cells. Life Sci. 2020;261:118348.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Wang G, Hu N, Yang HH, et al. Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china. PLoS One. 2013;8(5):e63826.
   PubMed Web of Science ®Google Scholar
• Oh SC, Sohn BH, Cheong JH, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9(1):1777.
   PubMedGoogle Scholar
• Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based human protein atlas. Nat Biotechnol. 2010;28(12):1248–1250.
   PubMed Web of Science ®Google Scholar
• Győrffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PloS One. 2013;8(12):e82241.
   PubMed Web of Science ®Google Scholar
• Li Y, Umbach DM, Krahn JM, et al. Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines. BMC Genomics. 2021;22(1):272.
   PubMed Web of Science ®Google Scholar
• Kim HK, Choi IJ, Kim CG, et al. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One. 2011;6(2):e16694.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–273.
   PubMed Web of Science ®Google Scholar
• Zhu H, Blake S, Chan KT, et al. Cystathionine β-synthase in physiology and cancer. Biomed Res Int. 2018;2018:3205125.
   PubMed Web of Science ®Google Scholar
• Jia H, Ye J, You J, et al. Role of the cystathionine β-synthase/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system. Oncol Rep. 2017;37(5):3001–3009.
   PubMed Web of Science ®Google Scholar
• Wang L, Yang Z, Wu Z, et al. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma. Medicine (Baltimore). 2020;99(38):e22255–e22255.
   PubMed Web of Science ®Google Scholar
• Kawahara B, Sen S, Mascharak PK. Reaction of carbon monoxide with cystathionine β-synthase: implications on drug efficacies in cancer chemotherapy. Future Med Chem. 2020;12(4):325–337.
   PubMed Web of Science ®Google Scholar